Not all individuals with CLL call for therapy. Irrespective of all latest developments, the iwCLL still endorses watchful observation for sufferers with asymptomatic sickness.86 This suggestion relies on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). ddbola selalu memberikan promosi https://albertg158ckl7.p2blogs.com/profile